<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Maraviroc</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Maraviroc">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Maraviroc</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Maraviroc</b>, sold under the brand names <b>Selzentry</b> (US) and <b>Celsentri</b> (EU), is an antiretroviral drug in the CCR5 receptor antagonist class used in the treatment of HIV infection. It is also classed as an entry inhibitor. It also appeared to reduce graft-versus-host disease in patients treated with allogeneic bone marrow transplantation for leukemia, in a Phase I/II study.<span class="mw-ref" id="cite_ref-5"><a href="#cite_note-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span><span class="mw-ref" id="cite_ref-6"><a href="#cite_note-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>



<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Maraviroc</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Maraviroc.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Maraviroc.svg.png" data-file-width="512" data-file-height="253" data-file-type="drawing" height="136" width="275"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Maraviroc_molecule_ball.png" tppabs="https://ptable.com/wiki/compounds/I/m/Maraviroc_molecule_ball.png" data-file-width="2000" data-file-height="1187" data-file-type="bitmap" height="148" width="250"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pronunciation</th><td><span class="rt-commentedText nowrap"><span class="IPA nopopups noexcerpt">/<span style="border-bottom:1px dotted"><span>m</span><span>ə</span><span>ˈ</span><span>r</span><span>æ</span><span>v</span><span>ɪ</span><span>r</span><span>ɒ</span><span>k</span></span>/</span></span> <i title="English pronunciation respelling">mə-<span style="font-size:90%">RAV</span>-i-rok</i> Selzentry: <span class="rt-commentedText nowrap"><span class="IPA nopopups noexcerpt">/<span style="border-bottom:1px dotted"><span>s</span><span>ɛ</span><span>l</span><span>ˈ</span><span>z</span><span>ɛ</span><span>n</span><span>t</span><span>r</span><span>i</span></span>/</span></span> <i title="English pronunciation respelling">sel-<span style="font-size:90%">ZEN</span>-tree</i><span> </span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Selzentry, Celsentri</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Other names</th><td>UK-427857, 4,4-Difluoro-<i>N</i>-[(1<i>S</i>)-3-{(1<i>R</i>,3<i>s</i>,5<i>S</i>)-3-[3-methyl-5-(propan-2-yl)-4<i>H</i>-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]octan-8-yl}-1-phenylpropyl]<br>cyclohexanecarboxamide</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/maraviroc.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/maraviroc.html'" tppabs="https://www.drugs.com/monograph/maraviroc.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a607076.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a607076.html'" tppabs="https://medlineplus.gov/druginfo/meds/a607076.html" class="external text external">a607076</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">EU</abbr></small><span>&nbsp;</span>EMA:<span>&nbsp;</span><span><a href="javascript:if(confirm('http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Maraviroc  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Maraviroc'" tppabs="http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Maraviroc" class="external text external">by INN</a></span></li>
<li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span><span>FDA:<span>&nbsp;</span><a href="javascript:if(confirm('https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Maraviroc&SearchType=BasicSearch  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Maraviroc&SearchType=BasicSearch'" tppabs="https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Maraviroc&SearchType=BasicSearch" class="external text external">Maraviroc</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>B1<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>B (No risk in non-human studies)<span> </span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth (tablets, oral solution)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>J05AX09<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=J05AX09  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=J05AX09'" tppabs="https://www.whocc.no/atc_ddd_index/?code=J05AX09" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">UK</abbr>:</small><span> </span>POM (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>℞-only<span> </span></li>
<li><small><abbr class="country-name">EU</abbr>:</small><span> </span>Rx-only<span> </span><span class="mw-ref" id="cite_ref-Celsentri_EPAR_1-0"><a href="#cite_note-Celsentri_EPAR-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>23%<span class="mw-ref" id="cite_ref-2"><a href="#cite_note-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>~76%<span class="mw-ref" id="cite_ref-PI_3-0"><a href="#cite_note-PI-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Liver (CYP, predominantly CYP3A)<span class="mw-ref" id="cite_ref-PI_3-1"><a href="#cite_note-PI-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolites</th><td>Secondary amine formed by <i>N</i>-dealkylation (major)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>14–18 hours<span class="mw-ref" id="cite_ref-PI_3-2"><a href="#cite_note-PI-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> (mean 16 hours)<span class="mw-ref" id="cite_ref-4"><a href="#cite_note-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Feces (76%), urine (20%)<span class="mw-ref" id="cite_ref-PI_3-3"><a href="#cite_note-PI-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">4,4-Difluoro-<i>N</i>-{(1<i>S</i>)-3-[3-(3-isopropyl- 5-methyl-4<i>H</i>-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl}cyclohexanecarboxamide</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=376348-65-1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=376348-65-1'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=376348-65-1" class="external text external">376348-65-1</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/3002977  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/3002977'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/3002977" class="external text external">3002977</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=806  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=806'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=806" class="external text external">806</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB04835  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB04835'" tppabs="https://www.drugbank.ca/drugs/DB04835" class="external text external">DB04835</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.20078004.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.20078004.html'" tppabs="http://www.chemspider.com/Chemical-Structure.20078004.html" class="external text external">20078004</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=MD6P741W8A  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=MD6P741W8A'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=MD6P741W8A" class="external text external">MD6P741W8A</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:63608  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:63608'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:63608" class="external text external">CHEBI:63608</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1201187  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1201187'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1201187" class="external text external">ChEMBL1201187</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">NIAID ChemDB</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemdb.niaid.nih.gov/CompoundDetails.aspx?AIDSNO=104834  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemdb.niaid.nih.gov/CompoundDetails.aspx?AIDSNO=104834'" tppabs="https://chemdb.niaid.nih.gov/CompoundDetails.aspx?AIDSNO=104834" class="external text external">104834</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID8048949  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID8048949'" tppabs="https://comptox.epa.gov/dashboard/DTXSID8048949" class="external text external">DTXSID8048949</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.124.927  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.124.927'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.124.927" class="external text external">100.124.927</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>29</sub><span>H</span><sub>41</sub><span>F</span><sub>2</sub><span>N</span><sub>5</sub><span>O</span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">513.678</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=Cc5nnc%28n5%5BC%40%40H%5D1C%5BC%40H%5D4CC%5BC%40%40H%5D%28C1%29N4CC%5BC%40H%5D%28NC%28%3DO%29C2CCC%28F%29%28F%29CC2%29c3ccccc3%29C%28C%29C  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=Cc5nnc%28n5%5BC%40%40H%5D1C%5BC%40H%5D4CC%5BC%40%40H%5D%28C1%29N4CC%5BC%40H%5D%28NC%28%3DO%29C2CCC%28F%29%28F%29CC2%29c3ccccc3%29C%28C%29C'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=Cc5nnc%28n5%5BC%40%40H%5D1C%5BC%40H%5D4CC%5BC%40%40H%5D%28C1%29N4CC%5BC%40H%5D%28NC%28%3DO%29C2CCC%28F%29%28F%29CC2%29c3ccccc3%29C%28C%29C" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Cc5nnc(n5[C@@H]1C[C@H]4CC[C@@H](C1)N4CC[C@H](NC(=O)C2CCC(F)(F)CC2)c3ccccc3)C(C)C</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C29H41F2N5O/c1-19(2)27-34-33-20(3)36(27)25-17-23-9-10-24(18-25)35(23)16-13-26(21-7-5-4-6-8-21)32-28(37)22-11-14-29(30,31)15-12-22/h4-8,19,22-26H,9-18H2,1-3H3,(H,32,37)/t23-,24+,25-,26-/m0/s1<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:GSNHKUDZZFZSJB-QYOOZWMWSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><sup><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup><span>&nbsp;</span>(what is this?)</span><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=477499940&page2=Maraviroc  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=477499940&page2=Maraviroc'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=477499940&page2=Maraviroc" class="external text external">(verify)</a></span></span></td></tr></tbody></table>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    
<p>Two randomized, placebo-controlled clinical trials, compared 209 people receiving optimized therapy plus a placebo to 426 people receiving optimized therapy plus 150<span>&nbsp;</span>mg maraviroc once daily and 414 patients receiving optimized therapy plus 150<span>&nbsp;</span>mg maraviroc twice daily.  At 48 weeks, 55% of participants receiving maraviroc once daily and 60% of participants receiving the drug twice daily achieved a viral load of less than 400 copies/mL compared with 26% of those taking placebo; about 44% of the once-daily and 45% of the twice-daily maraviroc group had a viral load of less than 50 copies/mL compared with about 23% of those who received placebo. In addition, those who received the entry inhibitor had a mean increase in CD4<sup>+</sup> cells of 110 cells/μL in the once-daily group, 106 cells/μL in the twice-daily group, and 56 cells/μL in the placebo group.<span class="mw-ref" id="cite_ref-JAMA_7-0"><a href="#cite_note-JAMA-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-8"><a href="#cite_note-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-9"><a href="#cite_note-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Side_effects">Side effects</h2></summary>
    
<p>Maraviroc can cause serious, life-threatening side effects. These include liver problems, skin reactions, and allergic reactions. An allergic reaction may happen before liver problems occur.<span class="mw-ref" id="cite_ref-10"><a href="#cite_note-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> Official labeling of Selzentry has black box warning for hepatotoxicity.<span class="mw-ref" id="cite_ref-PI_3-4"><a href="#cite_note-PI-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> The MOTIVATE trials showed no clinically relevant differences in safety between the maraviroc and placebo groups.<span class="mw-ref" id="cite_ref-JAMA_7-1"><a href="#cite_note-JAMA-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Mechanism_of_action">Mechanism of action</h2></summary>
    

<p>Maraviroc is an entry inhibitor. Specifically, maraviroc is a negative allosteric modulator of the CCR5 receptor, which is found on the surface of certain human cells. The chemokine receptor CCR5 is an essential co-receptor for most HIV strains and necessary for the entry process of the virus into the host cell. The drug binds to CCR5, thereby blocking the HIV protein gp120 from associating with the receptor. HIV is then unable to enter human macrophages and T cells.<span class="mw-ref" id="cite_ref-11"><a href="#cite_note-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> Because HIV can also use other coreceptors, such as CXCR4, an HIV tropism test such as a trofile assay must be performed to determine if the drug will be effective.<span class="mw-ref" id="cite_ref-12"><a href="#cite_note-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>Maraviroc, originally designated UK-427857, was developed by the drug company Pfizer in its UK labs located in Sandwich.  On April 24, 2007 the U.S. Food and Drug Administration advisory panel reviewing maraviroc's New Drug Application unanimously recommended approval for the new drug,<span class="mw-ref" id="cite_ref-13"><a href="#cite_note-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> and the drug received full FDA approval on August 6, 2007 for use in treatment experienced patients.<span class="mw-ref" id="cite_ref-14"><a href="#cite_note-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span></p>

<p>Maraviroc was approved for medical use in the European Union in September 2007.<span class="mw-ref" id="cite_ref-Celsentri_EPAR_1-1"><a href="#cite_note-Celsentri_EPAR-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Names">Names</h2></summary>
    
<p>Maraviroc is the International nonproprietary name (INN).<span class="mw-ref" id="cite_ref-INN_15-0"><a href="#cite_note-INN-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="See_also">See also</h2></summary>
    
<ul><li>Discovery and development of CCR5 receptor antagonists</li>
<li>Aplaviroc</li>
<li>Cenicriviroc</li>
<li>Vicriviroc</li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-Celsentri_EPAR-1"> <span id="mw-reference-text-cite_note-Celsentri_EPAR-1" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.ema.europa.eu/en/medicines/human/EPAR/celsentri  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ema.europa.eu/en/medicines/human/EPAR/celsentri'" tppabs="https://www.ema.europa.eu/en/medicines/human/EPAR/celsentri" class="external text external">"Celsentri EPAR"</a>. <i>European Medicines Agency (EMA)</i><span class="reference-accessdate">. Retrieved <span class="nowrap">31 July</span> 2020</span>.</cite></span></li><li id="cite_note-2"> <span id="mw-reference-text-cite_note-2" class="mw-reference-text"><cite id="CITEREFAbelRussellWhitlockRidgway2008" class="citation journal cs1">Abel S, Russell D, Whitlock LA, Ridgway CE, Nedderman AN, Walker DK (April 2008). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2311408  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2311408'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2311408" class="external text external">"Assessment of the absorption, metabolism and absolute bioavailability of maraviroc in healthy male subjects"</a>. <i>British Journal of Clinical Pharmacology</i>. <b>65</b> (Suppl 1): 60–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1365-2125.2008.03137.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1365-2125.2008.03137.x'" tppabs="https://doi.org/10.1111%2Fj.1365-2125.2008.03137.x" class="external text external">10.1111/j.1365-2125.2008.03137.x</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2311408  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2311408'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2311408" class="external text external">2311408</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18333867  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18333867'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18333867" class="external text external">18333867</a>.</cite></span></li><li id="cite_note-PI-3"> <span id="mw-reference-text-cite_note-PI-3" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=46f30ac5-c96b-429e-976d-8c5ee1c0761b  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=46f30ac5-c96b-429e-976d-8c5ee1c0761b'" tppabs="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=46f30ac5-c96b-429e-976d-8c5ee1c0761b" class="external text external">"Selzentry- maraviroc tablet, film coated Selzentry- maraviroc solution"</a>. <i>DailyMed</i>. 18 July 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">31 July</span> 2020</span>.</cite></span></li><li id="cite_note-4"> <span id="mw-reference-text-cite_note-4" class="mw-reference-text"><cite id="CITEREFAbelBackVourvahis2009" class="citation journal cs1">Abel S, Back DJ, Vourvahis M (2009). "Maraviroc: pharmacokinetics and drug interactions". <i>Antiviral Therapy</i>. <b>14</b> (5): 607–18. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19704163  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19704163'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19704163" class="external text external">19704163</a>.</cite></span></li><li id="cite_note-5"> <span id="mw-reference-text-cite_note-5" class="mw-reference-text"><cite id="CITEREFReshefLugerHexnerLoren2012" class="citation journal cs1">Reshef R, Luger SM, Hexner EO, Loren AW, Frey NV, Nasta SD,  et al. (July 2012). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568501  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568501'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568501" class="external text external">"Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease"</a>. <i>N. Engl. J. Med</i>. <b>367</b> (2): 135–45. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2FNEJMoa1201248  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2FNEJMoa1201248'" tppabs="https://doi.org/10.1056%2FNEJMoa1201248" class="external text external">10.1056/NEJMoa1201248</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568501  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568501'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568501" class="external text external">3568501</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22784116  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22784116'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22784116" class="external text external">22784116</a>.</cite></span></li><li id="cite_note-6"> <span id="mw-reference-text-cite_note-6" class="mw-reference-text"><cite class="citation pressrelease cs1"><a href="javascript:if(confirm('https://www.pennmedicine.org/news/news-releases/2012/july/hiv-drug-reduces-graftversusho  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.pennmedicine.org/news/news-releases/2012/july/hiv-drug-reduces-graftversusho'" tppabs="https://www.pennmedicine.org/news/news-releases/2012/july/hiv-drug-reduces-graftversusho" class="external text external">"HIV Drug Reduces Graft-versus-Host Disease in Bone Marrow Transplant Patients, Penn Study Shows"</a>. <i>Penn Medicine</i> (Press release).</cite></span></li><li id="cite_note-JAMA-7"> <span id="mw-reference-text-cite_note-JAMA-7" class="mw-reference-text"><cite id="CITEREFStephenson_J2007" class="citation journal cs1">Stephenson J (April 2007). "Researchers buoyed by novel HIV drugs: will expand drug arsenal against resistant virus". <i>JAMA</i>. <b>297</b> (14): 1535–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1001%2Fjama.297.14.1535  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Fjama.297.14.1535'" tppabs="https://doi.org/10.1001%2Fjama.297.14.1535" class="external text external">10.1001/jama.297.14.1535</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17426263  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17426263'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17426263" class="external text external">17426263</a>.</cite></span></li><li id="cite_note-8"> <span id="mw-reference-text-cite_note-8" class="mw-reference-text"><cite id="CITEREFEmmelkampRockstroh2007" class="citation journal cs1">Emmelkamp JM, Rockstroh JK (October 2007). "CCR5 antagonists: comparison of efficacy, side effects, pharmacokinetics and interactions--review of the literature". <i>European Journal of Medical Research</i>. <b>12</b> (9): 409–17. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17933722  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17933722'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17933722" class="external text external">17933722</a>.</cite></span></li><li id="cite_note-9"> <span id="mw-reference-text-cite_note-9" class="mw-reference-text"><cite class="citation journal cs1">"Maraviroc reduces viral load in naive patients at 48 weeks". <i>AIDS Patient Care and STDs</i>. <b>21</b> (9): 703–4. September 2007. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17941136  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17941136'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17941136" class="external text external">17941136</a>.</cite></span></li><li id="cite_note-10"> <span id="mw-reference-text-cite_note-10" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://aidsinfo.nih.gov/drugs/408/maraviroc--hiv-treatment/0/patient  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://aidsinfo.nih.gov/drugs/408/maraviroc--hiv-treatment/0/patient'" tppabs="https://aidsinfo.nih.gov/drugs/408/maraviroc--hiv-treatment/0/patient" class="external text external">"Maraviroc (HIV treatment) Dosage, Side Effects"</a>. <i>AIDSinfo</i>.</cite></span></li><li id="cite_note-11"> <span id="mw-reference-text-cite_note-11" class="mw-reference-text"><cite id="CITEREFLevy_JA2009" class="citation journal cs1">Levy JA (January 2009). "HIV pathogenesis: 25 years of progress and persistent challenges". <i>AIDS</i>. <b>23</b> (2): 147–60. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2FQAD.0b013e3283217f9f  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2FQAD.0b013e3283217f9f'" tppabs="https://doi.org/10.1097%2FQAD.0b013e3283217f9f" class="external text external">10.1097/QAD.0b013e3283217f9f</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19098484  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19098484'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19098484" class="external text external">19098484</a>.</cite></span></li><li id="cite_note-12"> <span id="mw-reference-text-cite_note-12" class="mw-reference-text"><cite id="CITEREFBiswasTambussiLazzarin2007" class="citation journal cs1">Biswas P, Tambussi G, Lazzarin A (May 2007). "Access denied? The status of co-receptor inhibition to counter HIV entry". <i>Expert Opinion on Pharmacotherapy</i>. <b>8</b> (7): 923–33. doi:<a href="javascript:if(confirm('https://doi.org/10.1517%2F14656566.8.7.923  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1517%2F14656566.8.7.923'" tppabs="https://doi.org/10.1517%2F14656566.8.7.923" class="external text external">10.1517/14656566.8.7.923</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17472538  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17472538'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17472538" class="external text external">17472538</a>.</cite></span></li><li id="cite_note-13"> <span id="mw-reference-text-cite_note-13" class="mw-reference-text"><a href="javascript:if(confirm('http://365gay.com/Newscon07/04/042407hiv.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://365gay.com/Newscon07/04/042407hiv.htm'" tppabs="http://365gay.com/Newscon07/04/042407hiv.htm" class="external text external">Gay News From 365Gay.com</a></span></li><li id="cite_note-14"> <span id="mw-reference-text-cite_note-14" class="mw-reference-text"><cite id="CITEREFKrauskopf2007" class="citation news cs1">Krauskopf, Lewis (August 6, 2007). <a href="javascript:if(confirm('https://www.reuters.com/article/ousiv/idUSN0642522320070806  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.reuters.com/article/ousiv/idUSN0642522320070806'" tppabs="https://www.reuters.com/article/ousiv/idUSN0642522320070806" class="external text external">"Pfizer wins U.S. approval for new HIV drug"</a>. <i>Reuters</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2007-08-06</span></span>.</cite></span></li><li id="cite_note-INN-15"> <span id="mw-reference-text-cite_note-INN-15" class="mw-reference-text"><cite id="CITEREFWorld_Health_Organization2005" class="citation journal cs1">World Health Organization (2005). "International nonproprietary names for pharmaceutical substances (INN): recommended INN: list 53". <i>WHO Drug Information</i>. <b>19</b> (1): 84–5. hdl:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://hdl.handle.net/10665%2F73323  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hdl.handle.net/10665%2F73323'" tppabs="https://hdl.handle.net/10665%2F73323" class="external text external">10665/73323</a></span>. License: CC BY-NC-SA 3.0 IGO.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Further_reading">Further reading</h2></summary>
    
<ul><li><cite id="CITEREFDean2015" class="citation book cs1">Dean L (2015). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/books/NBK279895/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/books/NBK279895/'" tppabs="https://www.ncbi.nlm.nih.gov/books/NBK279895/" class="external text external">"Maraviroc Therapy and CCR5 Genotype"</a>.  In Pratt VM, McLeod HL, Rubinstein WS,  et al. (eds.). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/books/NBK61999/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/books/NBK61999/'" tppabs="https://www.ncbi.nlm.nih.gov/books/NBK61999/" class="external text external"><i>Medical Genetics Summaries</i></a>. National Center for Biotechnology Information (NCBI). PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28520358  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28520358'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28520358" class="external text external">28520358</a>. Bookshelf ID: NBK279895.</cite></li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><cite class="citation web cs1"><a href="javascript:if(confirm('https://druginfo.nlm.nih.gov/drugportal/name/tecovirimat  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://druginfo.nlm.nih.gov/drugportal/name/tecovirimat'" tppabs="https://druginfo.nlm.nih.gov/drugportal/name/tecovirimat" class="external text external">"Tecovirimat"</a>. <i>Drug Information Portal</i>. U.S. National Library of Medicine.</cite></li>
<li><a href="javascript:if(confirm('https://meshb.nlm.nih.gov/record/ui?name=Maraviroc  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://meshb.nlm.nih.gov/record/ui?name=Maraviroc'" tppabs="https://meshb.nlm.nih.gov/record/ui?name=Maraviroc" class="external text external">Maraviroc</a><span> at the US National Library of Medicine </span>Medical Subject Headings<span> (MeSH)</span></li></ul>

<div role="navigation" class="navbox" aria-labelledby="Antiviral_drugs:_antiretroviral_drugs_used_against_HIV_(primarily_J05)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Antiviral_drugs:_antiretroviral_drugs_used_against_HIV_(primarily_J05)" style="font-size:114%;margin:0 4em">Antiviral drugs: antiretroviral drugs used against HIV (primarily J05)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Entry/fusion inhibitors <br> <i>(Discovery and development)</i></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>gp41</i> (<a href="Enfuvirtide.htm" tppabs="https://ptable.com/wiki/compounds/A/Enfuvirtide" title="Enfuvirtide">Enfuvirtide (ENF, T-20)</a>)</li>
<li><i>CCR5</i> (<a href="Maraviroc.htm" tppabs="https://ptable.com/wiki/compounds/A/Maraviroc" title="Maraviroc">Maraviroc (MVC)</a></li>
<li>Vicriviroc<sup>†</sup>, Cenicriviroc<sup>†</sup>, PRO 140<sup>†</sup>)</li>
<li><i>CD4</i> (Ibalizumab<sup>†</sup>, UB421<sup>§</sup>)</li>
<li><i>gp120</i> (Fostemsavir)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Reverse-transcriptase<br> inhibitors (RTIs)</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Nucleoside and<br> nucleotide (NRTI)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Nucleoside analogues/NRTIs:</i>  <a href="Abacavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Abacavir" title="Abacavir">Abacavir (ABC)</a>°<sup>#</sup></li>
<li><a href="Didanosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Didanosine" title="Didanosine">Didanosine (ddI)</a></li>
<li><a href="Emtricitabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Emtricitabine" title="Emtricitabine">Emtricitabine (FTC)</a>°</li>
<li><a href="Lamivudine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lamivudine" title="Lamivudine">Lamivudine (3TC)</a>°<sup>#</sup></li>
<li><a href="Stavudine.htm" tppabs="https://ptable.com/wiki/compounds/A/Stavudine" title="Stavudine">Stavudine (d4T)</a><sup>#</sup></li>
<li><a href="Zidovudine.htm" tppabs="https://ptable.com/wiki/compounds/A/Zidovudine" title="Zidovudine">Zidovudine (AZT, ZDV)</a><sup>#</sup></li>
<li>Amdoxovir<sup>†</sup></li>
<li>Apricitabine<sup>†</sup></li>
<li>Censavudine<sup>†</sup></li>
<li>Elvucitabine<sup>†</sup></li>
<li>Islatravir (EFdA)<sup>§</sup></li>
<li>Racivir<sup>†</sup></li>
<li>Stampidine<sup>†</sup></li>
<li><a href="Zalcitabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Zalcitabine" title="Zalcitabine">Zalcitabine (ddC)</a><sup>◊</sup></li></ul>

<ul><li><i>Nucleotide analogues/NtRTIs:</i>  Tenofovir disoproxil (TDF)°<sup>#</sup></li>
<li>Tenofovir alafenamide (TAF)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Non-nucleoside (NNRTI)<br><i>(Discovery and development)</i></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">1<sup>st</sup> generation</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Efavirenz.htm" tppabs="https://ptable.com/wiki/compounds/A/Efavirenz" title="Efavirenz">Efavirenz (EFV)</a>°<sup>#</sup></li>
<li><a href="Nevirapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nevirapine" title="Nevirapine">Nevirapine (NVP)</a><sup>#</sup></li>
<li><a href="Delavirdine.htm" tppabs="https://ptable.com/wiki/compounds/A/Delavirdine" title="Delavirdine">Delavirdine (DLV)</a><sup>◊</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">2<sup>nd</sup> generation</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>diarylpyrimidines</i>
<ul><li>Etravirine (ETR)</li>
<li>Rilpivirine (RPV)°</li></ul></li>
<li>Doravirine°</li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Integrase inhibitors<br>(Integrase strand transfer inhibitors (INSTI))</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Dolutegravir (DTG)°</li>
<li>Elvitegravir (EVG)°</li>
<li>Raltegravir (RAL)°</li>
<li>BI 224436<sup>†</sup></li>
<li>Cabotegravir<sup>†</sup></li>
<li>Bictegravir (BIC)<sup>†</sup></li>
<li>MK-2048<sup>†</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Maturation inhibitors</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Bevirimat<sup>†</sup></li>
<li>BMS-955176<sup>§</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Protease Inhibitors (PI)<br><i>(Discovery and development)</i></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">1<sup>st</sup> generation</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Amprenavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Amprenavir" title="Amprenavir">Amprenavir (APV)</a><sup>◊</sup></li>
<li><a href="Fosamprenavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Fosamprenavir" title="Fosamprenavir">Fosamprenavir (FPV)</a></li>
<li><a href="Indinavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Indinavir" title="Indinavir">Indinavir (IDV)</a><sup>◊</sup></li>
<li><a href="Lopinavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Lopinavir" title="Lopinavir">Lopinavir (LPV)</a></li>
<li><a href="Nelfinavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Nelfinavir" title="Nelfinavir">Nelfinavir (NFV)</a></li>
<li><a href="Ritonavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Ritonavir" title="Ritonavir">Ritonavir (RTV)</a><sup>#</sup></li>
<li><a href="Saquinavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Saquinavir" title="Saquinavir">Saquinavir (SQV)</a><sup>#</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">2<sup>nd</sup> generation</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Atazanavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Atazanavir" title="Atazanavir">Atazanavir (ATV)</a>°<sup>#</sup></li>
<li><a href="Darunavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Darunavir" title="Darunavir">Darunavir (DRV)</a>°<sup>#</sup></li>
<li><a href="Tipranavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Tipranavir" title="Tipranavir">Tipranavir (TPV)</a></li>
<li>TMC-310911<sup>§</sup></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Combined formulations</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Abacavir/lamivudine°<sup>#</sup></li>
<li>Abacavir/dolutegravir/lamivudine°</li>
<li>Abacavir/lamivudine/zidovudine</li>
<li>Atazanavir/cobicistat</li>
<li>Bictegravir/emtricitabine/tenofovir alafenamide</li>
<li>Darunavir/cobicistat</li>
<li>Darunavir/cobicistat/emtricitabine/tenofovir alafenamide</li>
<li>Dolutegravir/lamivudine</li>
<li>Dolutegravir/lamivudine/tenofovir</li>
<li>Dolutegravir/rilpivirine</li>
<li>Doravirine/lamivudine/tenofovir</li>
<li>Efavirenz/emtricitabine/tenofovir°<sup>#</sup></li>
<li>Efavirenz/lamivudine/tenofovir<sup>#</sup></li>
<li>Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide</li>
<li>Elvitegravir/cobicistat/emtricitabine/tenofovir°</li>
<li>Emtricitabine/tenofovir alafenamide</li>
<li>Emtricitabine/rilpivirine/tenofovir alafenamide</li>
<li>Emtricitabine/rilpivirine/tenofovir°</li>
<li>Emtricitabine/tenofovir°<sup>#</sup></li>
<li>Lamivudine/nevirapine/stavudine<sup>#</sup></li>
<li>Lamivudine/nevirapine/zidovudine<sup>#</sup></li>
<li>Lamivudine/raltegravir</li>
<li>Lamivudine/tenofovir</li>
<li>Lamivudine/zidovudine<sup>#</sup></li>
<li>Lopinavir/ritonavir°<sup>#</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Pharmacokinetic boosters</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Cobicistat (c)</li>
<li><a href="Ritonavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Ritonavir" title="Ritonavir">Ritonavir (r)</a><sup>#</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Experimental agents</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Uncoating inhibitors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>TRIM5alpha (gene)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Transcription inhibitors</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Tat antagonists</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Translation inhibitors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Trichosanthin</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"> BNAbs</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Elipovimab</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Abzyme</li>
<li>BIT225<sup>†</sup></li>
<li>Calanolide A</li>
<li>Ceragenin</li>
<li>Cyanovirin-N</li>
<li>Diarylpyrimidines</li>
<li><a href="Epigallocatechin_gallate.htm" tppabs="https://ptable.com/wiki/compounds/A/Epigallocatechin_gallate" title="Epigallocatechin gallate">Epigallocatechin gallate (EGCG)</a></li>
<li><a href="Foscarnet.htm" tppabs="https://ptable.com/wiki/compounds/A/Foscarnet" title="Foscarnet">Foscarnet</a></li>
<li>Fosdevirine<sup>†</sup></li>
<li>Griffithsin</li>
<li><a href="Hydroxycarbamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydroxycarbamide" title="Hydroxycarbamide">Hydroxycarbamide</a></li>
<li>KP-1461<sup>†</sup></li>
<li><a href="Miltefosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Miltefosine" title="Miltefosine">Miltefosine</a></li>
<li>Portmanteau inhibitors</li>
<li>Scytovirin</li>
<li>Seliciclib<sup>†</sup></li>
<li>Synergistic enhancers</li>
<li>Tre recombinase</li>
<li>Zinc finger protein transcription factor</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Failed agents</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Aplaviroc</li>
<li>Atevirdine</li>
<li>Brecanavir</li>
<li>Capravirine</li>
<li>Dexelvucitabine</li>
<li>Droxinavir</li>
<li>Lasinavir</li>
<li>Emivirine</li>
<li>Lersivirine</li>
<li>Lodenosine</li>
<li>Loviride</li>
<li>Mozenavir</li>
<li><span class="new">Palinavir</span></li>
<li><span class="new">Telinavir</span></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;"><div><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div> °DHHS <i>recommended</i> initial regimen options. <sup>◊</sup>Formerly or rarely used agent.<br></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Chemokine_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Chemokine_receptor_modulators" style="font-size:114%;margin:0 4em">Chemokine receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">CC</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">CCR1</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> CCL4 (MIP-1β)</li>
<li>CCL5 (RANTES)</li>
<li>CCL6</li>
<li>CCL9 (CCL10)</li>
<li>CCL14</li>
<li>CCL15</li>
<li>CCL16</li>
<li>CCL23</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">CCR2</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> CCL2</li>
<li>CCL8</li>
<li>CCL12</li>
<li>CCL16</li></ul>

<ul><li><i>NAMs:</i> Cenicriviroc (TAK-652, TBR-652)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">CCR3</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> CCL5 (RANTES)</li>
<li>CCL7</li>
<li>CCL11</li>
<li>CCL13</li>
<li>CCL15</li>
<li>CCL18</li>
<li>CCL24</li>
<li>CCL26</li>
<li>CCL28</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">CCR4</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> CCL3 (MIP-1α)</li>
<li>CCL5 (RANTES)</li>
<li>CCL17</li>
<li>CCL22</li></ul>

<ul><li><i>Antibodies:</i> Mogamulizumab (against CCR4)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">CCR5</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> CCL3 (MIP-1α)</li>
<li>CCL4 (MIP-1β)</li>
<li>CCL5 (RANTES)</li>
<li>CCL8</li>
<li>CCL11</li>
<li>CCL13</li>
<li>CCL14</li>
<li>CCL16</li></ul>

<ul><li><i>NAMs:</i> Aplaviroc</li>
<li>Cenicriviroc (TAK-652, TBR-652)</li>
<li><span class="new">INCB009471</span></li>
<li><a href="Maraviroc.htm" tppabs="https://ptable.com/wiki/compounds/A/Maraviroc" title="Maraviroc">Maraviroc</a></li>
<li>Vicriviroc</li></ul>

<ul><li><i>Antibodies:</i> PRO-140</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">CCR6</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> CCL20</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">CCR7</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> CCL19</li>
<li>CCL21</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">CCR8</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> CCL1</li>
<li>CCL16</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">CCR9</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> CCL25</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">CCR10</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> CCL27</li>
<li>CCL28</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">CCR11</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> CCL19</li>
<li>CCL21</li>
<li>CCL25</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Ungrouped</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Antibodies:</i> Bertilimumab (against CCL11)</li>
<li>Carlumab (against CCL2)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">CXC</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">CXCR1<br><small>(IL-8Rα)</small></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> CXCL6</li>
<li><span class="new">Emoctakin</span></li>
<li>Interleukin-8 (CXCL8, GCP-1)</li></ul>

<ul><li><i>Antagonists:</i> <span class="new">Navarixin</span></li></ul>

<ul><li><i>NAMs:</i> <span class="new">Ladarixin</span></li>
<li><span class="new">Reparixin (repertaxin)</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">CXCR2<br><small>(IL-8Rβ)</small></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> CXCL1 (MGSA)</li>
<li>CXCL2</li>
<li>CXCL3</li>
<li>CXCL5</li>
<li>CXCL6</li>
<li>CXCL7</li>
<li><span class="new">Emoctakin</span></li>
<li><span class="new">Garnocestim</span></li>
<li>Interleukin-8 (CXCL8, GCP-1)</li></ul>

<ul><li><i>Antagonists:</i> <span class="new">Danirixin</span></li>
<li><span class="new">Elubrixin</span></li>
<li><span class="new">Navarixin</span></li></ul>

<ul><li><i>NAMs:</i> <span class="new">Ladarixin</span></li>
<li><span class="new">Reparixin (repertaxin)</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">CXCR3</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> CXCL4 (PF4)</li>
<li>CXCL9 (MIG)</li>
<li>CXCL10 (IP-10)</li>
<li>CXCL11 (I-TAC)</li>
<li><span class="new">Iroplact</span></li></ul>

<ul><li><i>Antibodies:</i> Eldelumab (against CXCL10)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">CXCR4</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> MIF</li>
<li>SDF-1 (CXCL12)</li>
<li>Ubiquitin</li></ul>

<ul><li><i>Antagonists:</i> <span class="new">Mavorixafor</span></li>
<li>Plerixafor (AMD3100)</li></ul>

<ul><li><i>Antibodies:</i> Ulocuplumab (against CXCR4)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">CXCR5</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> CXCL13</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">CXCR6</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> CXCL16</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">CXCR7</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> CXCL11 (I-TAC)</li>
<li>SDF-1 (CXCL12)</li></ul>

<ul><li><i>PAMs:</i> Plerixafor (AMD3100)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">C (XC)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="XCR1" scope="row" class="navbox-group" style="width:1%">XCR1</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Lymphotactin-α (XCL1)</li>
<li>Lymphotactin-β (XCL2)</li></ul>

<ul><li><i>Antibodies:</i> Pateclizumab</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">CX3C</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="CX3CR1" scope="row" class="navbox-group" style="width:1%">CX3CR1</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Fractalkine (CX3CL1)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Others</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">CCBP2</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> CC (β) chemokines</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">CMKLR1</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Chemerin</li>
<li><span class="new">Resolvin E1</span></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<dl><dt>See also</dt>
<dd><i> Receptor/signaling modulators</i></dd>
<dd><i>Signaling peptide/protein receptor modulators</i></dd>
<dd><i>Cytokine receptor modulators</i></dd></dl>
</div></td></tr></tbody></table></div>











<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-08-01" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Maraviroc&oldid=970650781  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Maraviroc&oldid=970650781'" tppabs="https://en.wikipedia.org/wiki/?title=Maraviroc&oldid=970650781">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>